Form 8-K - Current report:
SEC Accession No. 0001213900-20-018233
Filing Date
2020-07-22
Accepted
2020-07-22 08:13:48
Documents
4
Period of Report
2020-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea124403-8k_neuroone.htm 8-K 21778
2 EXCLUSIVE DEVELOPMENT AND DISTRIBUTION AGREEMENTDATED AS OF JULY 20, 2020 BY AND ea124403ex10-1_neuroone.htm EX-10.1 236425
3 PRESS RELEASE DATED JULY 22, 2020 ISSUED BY NEUROONE ea124403ex99-1_neuroone.htm EX-99.1 10846
4 GRAPHIC image_001.gif GRAPHIC 2592
  Complete submission text file 0001213900-20-018233.txt   274015
Mailing Address 7599 ANAGRAM DR EDEN PRAIRIE MN 55344
Business Address 7599 ANAGRAM DR EDEN PRAIRIE MN 55344 (952) 426-1383
NEUROONE MEDICAL TECHNOLOGIES Corp (Filer) CIK: 0001500198 (see all company filings)

EIN.: 270863354 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54716 | Film No.: 201040290
SIC: 3841 Surgical & Medical Instruments & Apparatus